Skip to main content
SpringerLink
Log in

Effects of thymoleptics on behaviour associated with changes in brain dopamine

I. Potentiation of Dopa-induced gnawing of mice

  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Abstract

The thymoleptics imipramine, desipramine, protriptyline, nortriptyline, chlorimipramine and amitriptyline all potentiate gnawing of mice induced by Dopa following the decarboxylase inhibitor Ro 4-4602.

The gnawing behaviour is probably associated with the increase in brain dopamine resulting from this treatment. Thymoleptics also affect other types of behaviour associated with brain dopamine. The relevance of these effects to clinical antidepressive effect and their possible utilization for preclinical screening tests is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ajuriaguerra, J. de, Constantinidis, J., Eisenring, J. J., Yanniotis, G., Tissot, R.: Behaviour disorders and l-DOPA therapy in Parkinson's syndrome. In: Parkinson's disease, Vol. 1, J. Siegfried, ed., pp. 201–217. Bern-Stuttgart-Vienna: H. Huber 1972

    Google Scholar 

  • De Alarcon, R., Carney, M. W. P.: Severe depressive mood changes following slow-release intramuscular fluphenazine injection. Brit. Med. J. 1969III, 564–567

    Google Scholar 

  • Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, R.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513–523 (1970)

    Google Scholar 

  • Blomberg, L.-H., Eriksson, G.: Imipramin (Tofranil) vid behandling av parkinsonism. Svenska LÄk.-Tidn. 58, 2500–2503 (1961)

    Google Scholar 

  • Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine. Europ. J. Pharmol. 5, 367–373 (1969)

    Google Scholar 

  • Eble, J. N.: A proposed mechanism for the depressor effect of dopamine in the anesthetized dog. J. Pharmacol. 145, 64–70 (1964)

    Google Scholar 

  • Eisenring, J.-J., Dick, P., Tissot, R., Yanniotis, G.: Association l-DOPA, désipramine et inhibieur de la décarboxylase dans le traitement de la dépression. Psychopharmacologia (Berl.) 33, 95–101 (1973)

    Google Scholar 

  • Everett, G. M.: The DOPA response potentiation test and its use in screening for antidepressant drugs. In: Anti-depressant drugs. S. Garattini and M. N. G. Dukes, eds., pp. 164–167. Amsterdam: International Congress Series No. 122, Excerpta Medica Foundation 1967

    Google Scholar 

  • Glowinski, J., Axelrod, J., Iversen, L. L.: Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J. Pharmacol. exp. Ther. 153, 30–41 (1966)

    Google Scholar 

  • Goldberg, L. I.: Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol. Rev. 24, 1–29 (1972).

    Google Scholar 

  • Halaris, A., Belendiuk, K., Freedman, D.: Antidepressant drugs affect brain dopamine. J. Pharmacol. 5, 40 (1974)

    Google Scholar 

  • Helmchen, H., Hippius, H.: Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt 38, 455–458 (1967)

    Google Scholar 

  • HÄfliger, F., Burckhard, V.: Iminodibenzyl and related compounds. In: Psychopharmacological agents, Vol. 1, M. Gordon, ed., pp. 35–101. New York-London: Academic Press 1964

    Google Scholar 

  • Kabes, J., Taussigová, D., Dostal, T., Vinar, O.: l-DOPA and tricyclic antidepressants in affective disorders. A pilot study. Activ. nerv. sup. (Praha) 16, 186–188 (1974)

    Google Scholar 

  • Kadzielawa, K., Popielarski, M.: Potentiation by desipramine of the pressor and depressor effects of dopamine. J. Pharm. Pharmacol. 23, 550–551 (1971)

    Google Scholar 

  • Klein, R. F.: Behavioral effects of imipramine and phenothiazines: implications for a psychiatric pathogenetic theory and theory of drug action. In: Recent advances in biological psychiatry, Vol. 7, J. Wortis, ed., pp. 273–287. New York: Plenum Press 1965

    Google Scholar 

  • Maj, J., Grabowska, ML, Gajda, L.: Effect of apomorphine on motility in rats. Europ. J. Pharmacol. 17, 208–214 (1972)

    Google Scholar 

  • McGrath, W. R., Ketteler, H. J.: Potentiation of the antireserpine effects of dihydroxyphenylalanine by antidepressants and stimulants. Nature (Lond.) 199, 917–918 (1963)

    Google Scholar 

  • Mandell, A. J., Markham, C., Fowler, W.: Parkinson's syndrome, depression and imipramine. Calif. Med. 95, 12–14 (1961)

    Google Scholar 

  • Meng, H. H., Brand, U.: Untersuchungen über die Stereotypien nach Amphetamin und Apomorphin sowie deren pharmakologische Beeinflussung. Psychopharmacologia (Berl.) 21, 212–228 (1971)

    Google Scholar 

  • Molander, L., Randrup, A.: Investigation of the mechanism by which l-DOPA induces gnawing in mice. Acta pharmacol. (Kbh.) 34, 312–324 (1974)

    Google Scholar 

  • Morselli, P. L., Rizzo, M., Zaccala, M., Garattini, S.: Haloperidol-desipramine interaction in mice, rats and man. Chem.-Biol. Interactions 2, 160–164 (1970)

    Google Scholar 

  • MØller Nielsen, I., Nymark, M., Hougs, W., Pedersen, V.: The pharmacological properties of Melitracen (N 7001) and Litracen (N 7049). Arzneimittel-Forsch. 22, 135–140 (1966)

    Google Scholar 

  • Nielsen, M., Eplov, L., Scheel-Krüger, J.: Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-l-DOPA in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 15–28 (1974)

    Google Scholar 

  • Nielsen, M., Eplov, L., Scheel-Krüger, J.: The effect of amitriptyline, desipramine and imipramine on the in vivo brain synthesis of 3H-noradrenaline from 3H-l-DOPA in the rat. Psychopharmacologia (Berl.) 41, 249–254 (1975)

    Google Scholar 

  • NybÄck, H., Borzecki, Z., Sedvall, G.: Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain: effect of some psychotropic drugs. Europ. J. Pharmacol. 4, 395–403 (1968)

    Google Scholar 

  • NybÄck, H.: Effects of neuroleptic drugs on brain catecholamine neurons. Thesis from the Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden, 1971

    Google Scholar 

  • Pedersen, V.: Potensering af apomorfineffekt (tvangsgnavning) på mus. Lecture. Nordisk FarmakołogimØde, KØbenhavn 1967

    Google Scholar 

  • Persson, T., Waldeck, B.: Effect of protriptyline on the formation of [3H]noradrenaline from [3H]dopa. J. Pharm. Pharmacol. 20, 966–968 (1968)

    Google Scholar 

  • Pscheidt, G. R., Himwich, H. E.: Imipramine affects dopamine uptake by rat brain. J. Pharm. Pharmacol. 20, 809–810 (1968)

    Google Scholar 

  • Randrup, A.: Role of brain dopamine in the antipsychotic effect of neuroleptics evidence from studies of amphetamine-neuroleptic interaction. In: The neuroleptics. D. P. Bobon, P. A. J. Janssen and J. Bobon, eds., pp. 60–65. Basel: S. Karger 1970

    Google Scholar 

  • Ross, S. B., Renyi, ögren, S.-O.: A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices. Life Sci. 10, 1267–1277 (1971)

    Google Scholar 

  • Van Rossum, J. M., Janssen, P. A. J., Boissier, J. R., Julou, L., Loew, D. M., MØller Nielsen, I., Munkvad, I., Randrup, A., Stille, G., Tedeschi, D. H.: Pharmacology. In: The neuroleptics, vol. 5, D. P. Bobon, P. A. J. Janssen, and J. Bobon, eds., pp. 23–32. Basel: S. Karger 1970

    Google Scholar 

  • Sandler, M.: Catecholamine synthesis and metabolism in man: clinical implications (with special reference to Parkinsonism). In: Handbook of experimental pharmacology: catecholamines, H. Blaschko and E. Muscholl, eds., pp. 845–899. 1971. Berlin-Heidelberg-New York: Springer 1971

    Google Scholar 

  • Scheel-Krüger, J.: Central effect of anticholinergic drugs measured by the apomorphine gnawing test in mice. Acta pharmacol. (Kbh.) 28, 1–16 (1970)

    Google Scholar 

  • Soudijn, W., van Wijngaarden, I.: Localization of [3H]pimozide in the rat brain in relation to its anti-amphetamine potency. J. Pharm. Pharmacol. 24, 773–780 (1972)

    Google Scholar 

  • Steinberg, M. I., Smith, C. B.: Effects of desmethylimipramine and cocaine on the uptake, retention and metabolism of H3-tyramine in rat brain slices. J. Pharmacol. exp. Ther. 173, 176–192 (1970)

    Google Scholar 

  • Strömberg, U., Waldeck, B.: Behavioural and biochemical interaction between caffeine and l-DOPA. J. Pharm. Pharmacol. 25, 302–308 (1973a)

    Google Scholar 

  • Strömberg, U., Waldeck, B.: Further studies on the behavioural and biochemical interaction between caffeine and l-DOPA. J. Neural Transmiss. 34, 241–252 (1973b)

    Google Scholar 

  • Ther, L., Schramm, H.: Apomorphin-Synergismus (Zwangsnagen bei MÄusen) als Test zur Differenzierung psychotroper Substanzen. Arch. int. Pharmacodyn. 138, 302–310 (1962)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacological Department, AB Ferrosan, Fack, S-20110, Malmö 1, Sweden

    Lars Molander & Axel Randrup

  2. Dept. E, Sct. Hans Hospital, DK-4000, Roskilde, Denmark

    Lars Molander & Axel Randrup

Authors
  1. Lars Molander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Axel Randrup
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molander, L., Randrup, A. Effects of thymoleptics on behaviour associated with changes in brain dopamine. Psychopharmacologia 45, 261–265 (1976). https://doi.org/10.1007/BF00421137

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00421137

Key words

Search

Navigation